English

pharmaceuticals

Health news

Weight-loss pill "Wegovy" available in German pharmacies from 1 September

ADVERTISEMENT

ADVERTISEMENT

The Big Question

The rising threat of antimicrobial resistance and its economic toll

More people are expected to die every year from superbugs than cancer by 2050. Antibiotic resistance is ‘a major threat’ to our health and economy, according to Japanese pharma experts.

The Ring

Europe’s healthcare - A right or a business? MEPs debate in The Ring

In this special edition of The Ring, broadcast from the Euronews Health Summit, MEPs Stine Bosse (Renew Europe) and Tilly Metz (The Greens/EFA) go head-to-head to debate who should pay for European health innovation.

Health news

EU's ‘unique’ healthcare system under pressure, says EU Commissioner

Simplification is key to boosting Europe’s healthcare competitiveness, fostering innovation, and reaching patients across the region, according to European Health Commissioner Olivér Várhelyi.

Health news

Experimental oral drug lowers ‘bad’ cholesterol by 60%, study finds

A new pill in the final phase of clinical trials cuts harmful cholesterol by 60% in high-risk patients.

ADVERTISEMENT

Health news

Why weight loss drugs aren't Denmark's trump card in Greenland dispute

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

Health news

EU unveils new pharma package to boost industry

The European Union has agreed on new pharmaceutical rules introducing new incentives to boost the pharmaceutical industry amid accessibility concerns.

Business

UK and US agree on zero-tariff pharma deal after months of tensions

London and Washington have found a compromise that would avoid US tariffs on British medicines — but only after the UK agreed to pay more for cutting-edge drugs.

Business

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

Healthcare

New malaria treatment could fight growing threat of drug resistance

Drugmaker Novartis said it will move quickly to ask regulators to approve the new medicine.

Business

Markets exhale as Novo Nordisk withdraws from Metsera bidding war

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.

Germany

This is how dependent Germany is on Chinese medicines

Germany sold more than 15 million tonnes of pharmaceutical products to China in 2024, while China sold more than 33 million tonnes to Germany.

Business

Pfizer agrees to lower prescription drug costs for Medicaid

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

Business

Big Pharma’s retreat: Is NHS pricing behind investor pullbacks?

Multinational pharmaceutical firms are pulling pack or pausing investments in the UK, blaming a lack of competitive drug pricing.

Markets

AstraZeneca to list shares in New York, without leaving the UK

Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.

Europe in Motion

EU high-tech exports recover: What's the most profitable sector?

Pharma has become the EU's most valuable high-tech export, driving the bloc's first trade surplus in years. But can it survive the impact of US tariffs?

Economy

Trump to put import taxes on pharma, home furnishings, heavy trucks

While Trump did not provide a legal justification for the tariffs, he appeared to stretch the bounds of his role as commander-in-chief by stating on Truth Social that the taxes on imported kitchen cabinets and sofas were needed “for national security and other reasons".